Actively Recruiting
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-03-06
119
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).
CONDITIONS
Official Title
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Able to understand and give informed consent
- For healthy volunteers: no known cancer diagnosis
- For patients in Study Aim 1 and 3: at least one untreated brain metastasis larger than 1 cm
- For patients in Study Aim 3: planned stereotactic radiosurgery (SRS) treatment
You will not qualify if you...
- Pregnant or breastfeeding women
- Pre-existing medical conditions including risk of seizures, claustrophobia, or higher risk of cardiac arrest
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
Research Team
O
Ouri Cohen, PhD
CONTACT
N
Nelson Moss, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here